In adult DM, increased risk of cancer [71,75,76,77] and calcinosis [75,76,78] were reported in at least two ethnic groups, while severe muscle involvement, subcutaneous edema, and dysphagia were reported in US cohorts [75,76] in association with the anti-NXP2 antibody. Here, MORC3 is linked to calcinosis.